327 related articles for article (PubMed ID: 33122827)
1. Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1.
Zhai S; Xu Z; Xie J; Zhang J; Wang X; Peng C; Li H; Chen H; Shen B; Deng X
Oncogene; 2021 Jan; 40(2):277-291. PubMed ID: 33122827
[TBL] [Abstract][Full Text] [Related]
2. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription.
Liu S; Zheng Y; Zhang Y; Zhang J; Xie F; Guo S; Gu J; Yang J; Zheng P; Lai J; Yin L; Wang H
Theranostics; 2020; 10(23):10634-10651. PubMed ID: 32929371
[No Abstract] [Full Text] [Related]
3. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA MAPKAPK5-AS1 promotes colorectal cancer progression by cis-regulating the nearby gene MK5 and acting as a let-7f-1-3p sponge.
Yang T; Chen WC; Shi PC; Liu MR; Jiang T; Song H; Wang JQ; Fan RZ; Pei DS; Song J
J Exp Clin Cancer Res; 2020 Jul; 39(1):139. PubMed ID: 32690100
[TBL] [Abstract][Full Text] [Related]
5. LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p.
Wang X; Gao X; Tian J; Zhang R; Qiao Y; Hua X; Shi G
Arch Biochem Biophys; 2020 Aug; 689():108469. PubMed ID: 32590069
[TBL] [Abstract][Full Text] [Related]
6. LINC00261 suppresses human colon cancer progression via sponging miR-324-3p and inactivating the Wnt/β-catenin pathway.
Yan D; Liu W; Liu Y; Luo M
J Cell Physiol; 2019 Dec; 234(12):22648-22656. PubMed ID: 31183860
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
Han Q; Li J; Xiong J; Song Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
[TBL] [Abstract][Full Text] [Related]
8. Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer.
Qin Y; Hu Q; Ji S; Xu J; Dai W; Liu W; Xu W; Sun Q; Zhang Z; Ni Q; Yu X; Zhang B; Xu X
Cell Prolif; 2019 May; 52(3):e12603. PubMed ID: 30932257
[TBL] [Abstract][Full Text] [Related]
9. LncRNA RGMB-AS1 facilitates pancreatic cancer cell proliferation and migration but inhibits cell apoptosis via miR-574-3p/PIM3 axis.
Song W; Shi C
Am J Physiol Gastrointest Liver Physiol; 2021 Nov; 321(5):G477-G488. PubMed ID: 34468207
[TBL] [Abstract][Full Text] [Related]
10. LINC00261/microRNA-550a-3p/SDPR axis affects the biological characteristics of breast cancer stem cells.
Li Y; Wu C
IUBMB Life; 2021 Jan; 73(1):188-201. PubMed ID: 33274565
[TBL] [Abstract][Full Text] [Related]
11. LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis.
Hua Q; Jin M; Mi B; Xu F; Li T; Zhao L; Liu J; Huang G
J Hematol Oncol; 2019 Sep; 12(1):91. PubMed ID: 31488218
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.
Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J
Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG14 potentiates pancreatic cancer progression via modulation of annexin A2 expression by acting as a competing endogenous RNA for miR-613.
Deng PC; Chen WB; Cai HH; An Y; Wu XQ; Chen XM; Sun DL; Yang Y; Shi LQ; Yang Y
J Cell Mol Med; 2019 Nov; 23(11):7222-7232. PubMed ID: 31513352
[TBL] [Abstract][Full Text] [Related]
14. LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539.
Nai Y; Pan C; Hu X; Ma Y
Cancer Med; 2020 Jan; 9(2):757-767. PubMed ID: 31789465
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
Feng Z; Chen R; Huang N; Luo C
Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis.
Wang H; Chen W; Yang P; Zhou J; Wang K; Tao Q
Cancer Biol Ther; 2019; 20(4):461-473. PubMed ID: 30404587
[TBL] [Abstract][Full Text] [Related]
18. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
19. Novel circular RNA circSLIT2 facilitates the aerobic glycolysis of pancreatic ductal adenocarcinoma via miR-510-5p/c-Myc/LDHA axis.
Guan H; Luo W; Liu Y; Li M
Cell Death Dis; 2021 Jun; 12(7):645. PubMed ID: 34168116
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
Yu L; Chen D; Song J
Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
